Skip to content

Form 4 filed by Pershing Edward

Pershing Edward filed this Form 4 on PROVECTUS BIOPHARMACEUTICALS, INC. with 2 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-30 15:32:13 UTC.

Accession
0001493152-26-049383
Filed
2026-10-30
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: PROVECTUS BIOPHARMACEUTICALS, INC. (CIK 315545)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
8% Unsecured Convertible Promissory Note derivative2026-10-30M exercised-$0D
Series D-1 Convertible Preferred Stock derivative2026-10-30M exercised+24,544$03,030,677D